Target intelligence / Profile preview

Non-Asparagine Synthetase (ASNS) messenger RNAs with partial complementarity to the siRNA seed region (Off-target mRNAs)

Target
Off-target mRNAs
Molecular classification
Messenger RNA, Nucleic acid, Other
01

Overview

Non-Asparagine Synthetase (ASNS) messenger RNAs with partial complementarity to the siRNA seed region refer to a group of unintended transcripts that are downregulated during the use of RNA interference (RNAi) directed at Asparagine Synthetase. This off-target effect is primarily mediated by the 'seed region' of the siRNA (nucleotides 2 through 8), which can bind to the 3' untranslated regions (UTRs) of various mRNAs that share partial sequence complementarity (Jackson et al., 2003, Nature Biotechnology). This interaction mimics the natural regulatory mechanism of microRNAs, leading to the degradation or translational repression of these non-target genes (Birmingham et al., 2006, Nature Methods). In therapeutic contexts, such as the development of ASNS inhibitors for asparagine-dependent cancers, these off-target effects can lead to significant cellular toxicity and complicate the interpretation of phenotypic outcomes (Fedorov et al., 2006, RNA). Identifying these transcripts is crucial for the design of highly specific siRNAs, often involving chemical modifications like 2'-O-methyl groups to the seed region to reduce unintended binding. Consequently, these mRNAs are monitored as a safety concern rather than being therapeutic targets themselves.

Other names
Off-target transcriptsSeed-matched off-targetsUnintended mRNA targetssiRNA off-targets
02

Mechanism of action

RNA interference (RNAi) mediated degradation or translational repression through seed-region complementarity, mimicking microRNA-like regulation (Jackson et al., 2003, Nature Biotechnology).

03

Biological functions

Gene expressionProtein synthesisOther
04

Disease associations

CancerOther
05

Safety considerations

Unintended gene silencingCellular toxicityOff-target effectsPotential for hepatotoxicity or immune activation
06

Interacting drugs

Small interfering RNA (siRNA)

1 more in the full profile.

07

Biomarkers

Transcriptome profilingRNA-seqOff-target signature analysis

Beyond the preview

Go deeper on Non-Asparagine Synthetase (ASNS) messenger RNAs with partial complementarity to the siRNA seed region (Off-target mRNAs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-Asparagine Synthetase (ASNS) messenger RNAs with partial complementarity to the siRNA seed region (Off-target mRNAs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call